Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 544

1.

Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.

Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Acker MA, Goldstein DL, Silvestry SC, Milano CA, Baldwin JT, Pinney S, Eduardo Rame J, Miller MA.

J Heart Lung Transplant. 2014 Jan;33(1):12-22. doi: 10.1016/j.healun.2013.11.001. Epub 2013 Nov 27. Erratum in: J Heart Lung Transplant. 2015 Oct;34(10):1356. Timothy Baldwin, J [corrected to Baldwin, J T].

PMID:
24418730
2.

Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.

Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, Rogers J, Slaughter MS, Stevenson LW.

J Heart Lung Transplant. 2015 Dec;34(12):1515-26. doi: 10.1016/j.healun.2015.10.024.

PMID:
26681121
3.

Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.

Cowger JA, Romano MA, Shah P, Shah N, Mehta V, Haft JW, Aaronson KD, Pagani FD.

J Heart Lung Transplant. 2014 Jan;33(1):35-43. doi: 10.1016/j.healun.2013.08.021. Epub 2013 Nov 28.

PMID:
24418732
4.

Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.

Ravichandran AK, Parker J, Novak E, Joseph SM, Schilling JD, Ewald GA, Silvestry S.

J Heart Lung Transplant. 2014 Jan;33(1):44-50. doi: 10.1016/j.healun.2013.08.019. Epub 2013 Nov 14.

PMID:
24418733
5.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937
6.

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.

Holman WL, Naftel DC, Eckert CE, Kormos RL, Goldstein DJ, Kirklin JK.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):437-41.e1. doi: 10.1016/j.jtcvs.2013.02.018. Epub 2013 Mar 13.

7.

Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data.

Smedira NG, Blackstone EH, Ehrlinger J, Thuita L, Pierce CD, Moazami N, Starling RC.

J Heart Lung Transplant. 2015 Dec;34(12):1527-34. doi: 10.1016/j.healun.2015.10.027.

PMID:
26681122
8.

An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.

Najjar SS, Slaughter MS, Pagani FD, Starling RC, McGee EC, Eckman P, Tatooles AJ, Moazami N, Kormos RL, Hathaway DR, Najarian KB, Bhat G, Aaronson KD, Boyce SW; HVAD Bridge to Transplant ADVANCE Trial Investigators.

J Heart Lung Transplant. 2014 Jan;33(1):23-34. doi: 10.1016/j.healun.2013.12.001. Epub 2013 Dec 12.

9.

Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.

Stulak JM, Davis ME, Haglund N, Dunlay S, Cowger J, Shah P, Pagani FD, Aaronson KD, Maltais S.

J Thorac Cardiovasc Surg. 2016 Jan;151(1):177-89. doi: 10.1016/j.jtcvs.2015.09.100. Epub 2015 Nov 4.

PMID:
26545967
10.

Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD.

J Am Coll Cardiol. 2011 May 10;57(19):1890-8. doi: 10.1016/j.jacc.2010.10.062. Erratum in: J Am Coll Cardiol. 2011 Nov 8;58(20):2142.

11.

Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.

Cabrera AG, Sundareswaran KS, Samayoa AX, Jeewa A, McKenzie ED, Rossano JW, Farrar DJ, Frazier OH, Morales DL.

J Heart Lung Transplant. 2013 Nov;32(11):1107-13. doi: 10.1016/j.healun.2013.07.012. Epub 2013 Aug 31.

PMID:
24002006
12.

Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.

Cleveland JC Jr, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD, Kirklin JK.

J Heart Lung Transplant. 2011 Aug;30(8):862-9. doi: 10.1016/j.healun.2011.04.004. Epub 2011 May 31.

PMID:
21621423
13.

Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).

Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ; HeartMate II Clinical Investigators.

J Am Coll Cardiol. 2014 May 6;63(17):1751-7. doi: 10.1016/j.jacc.2014.01.053. Epub 2014 Mar 5.

14.

The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.

Tellor BR, Smith JR, Prasad SM, Joseph SM, Silvestry SC.

J Heart Lung Transplant. 2014 Jan;33(1):94-101. doi: 10.1016/j.healun.2013.11.002. Epub 2013 Nov 25.

PMID:
24418735
15.

A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.

Katz JN, Jensen BC, Chang PP, Myers SL, Pagani FD, Kirklin JK.

J Heart Lung Transplant. 2015 May;34(5):701-9. doi: 10.1016/j.healun.2014.10.002. Epub 2014 Nov 4.

PMID:
25582036
16.

Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.

Boyle AJ, Jorde UP, Sun B, Park SJ, Milano CA, Frazier OH, Sundareswaran KS, Farrar DJ, Russell SD; HeartMate II Clinical Investigators.

J Am Coll Cardiol. 2014 Mar 11;63(9):880-8. doi: 10.1016/j.jacc.2013.08.1656. Epub 2013 Dec 11.

17.

Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.

Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP.

J Heart Lung Transplant. 2014 Jan;33(1):51-9. doi: 10.1016/j.healun.2013.10.005. Epub 2013 Nov 28.

PMID:
24290832
18.

Continuous-flow devices and percutaneous site infections: clinical outcomes.

Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, Kirklin J.

J Heart Lung Transplant. 2012 Nov;31(11):1151-7. doi: 10.1016/j.healun.2012.05.004. Epub 2012 Jul 4.

PMID:
22766022
19.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
20.

Surgical technique influences HeartMate II left ventricular assist device thrombosis.

Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA.

Ann Thorac Surg. 2013 Oct;96(4):1259-65. doi: 10.1016/j.athoracsur.2013.05.081. Epub 2013 Aug 20.

PMID:
23968757

Supplemental Content

Support Center